With the ongoing race in the pharmaceutical industry to discover the next silver bullet, the robust specialty drug market continues to grow year after year. We have all seen the statistics:
Health insurance providers are constantly looking for innovative solutions to contain the cost without compromising the health of their members. Using data analytics to understand the various trends around all medications that affect the overall cost- frequency of scripts written, brand vs. generic drugs dispensed, medication adherence, population profile, prescribers’ profile, disease burden, and much more. In partnership with PBMs, this powerful set of data analytics can be made available at the individual patient and provider level at the point of care (or place of service), which assists in better clinical decision support consequently leading to lower cost of care.
The webinar, a partnership between CVS Caremark and HDMS, educates health insurance providers on innovative solutions to specialty drug cost containment through the use of data analytics.
Vice President, Specialty Solutions
Robert O’Brien is a registered pharmacist and leads teams at CVS Caremark that focus on controlling specialty trends, maximizing clinical outcomes and enhancing specialty product development.
Senior Clinical Consultant
Rani Aravamudhan is a trained physician with a proven track record in value based care, population health, and analytics.